Note: Ingredients listed on restricted chemical lists
EC/CAS
203-441-9/106-91-2
Name of the chemical
Glycidyl methacrylate
Concentration
<= 100 %
General Information
Version
8.3
Revision date
2024-11-07
Product name
2,3-Epoxypropyl methacrylate (stabilised with hydroquinone monomethyl ether) for synthesis
CAS No.
106-91-2
REACH No
01-2119444916-30-XXXX
1.2.1 Relevant identified uses
Chemical for synthesis
Icons in SDS
Company Information
company name
Merck Pty Ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H311, H314, H317, H318, H335, H341, H350, H360F, H372
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity, (Category 4) H302: Harmful if swallowed. Acute toxicity, (Category 3) H311: Toxic in contact with skin. Skin corrosion, (Sub-category H314: Causes severe skin burns and eye 1C) damage. Serious eye damage, (Category H318: Causes serious eye damage. 1) Skin sensitization, (Category 1) H317: May cause an allergic skin reaction. Germ cell mutagenicity, H341: Suspected of causing genetic (Category 2) defects. Carcinogenicity, (Category 1B) H350: May cause cancer. Reproductive toxicity, (Category H360F: May damage fertility. 1B) Specific target organ toxicity - H335: May cause respiratory irritation. single exposure, (Category 3), Respiratory system Specific target organ toxicity - H372: Causes damage to organs through repeated exposure, (Category 1) prolonged or repeated exposure.
2.2 Label elements
Labelling
Signal word
Danger Danger
Hazard statements
H302 Harmful if swallowed. H311 Toxic in contact with skin. H314 Causes severe skin burns and eye damage. H317 May cause an allergic skin reaction. H335 May cause respiratory irritation. H341 Suspected of causing genetic defects. H350 May cause cancer. H360F May damage fertility. H372 Causes damage to organs through prolonged or repeated exposure. Restricted to professional users. Reduced Labeling (<= 125 ml) H311 Toxic in contact with skin. H317 May cause an allergic skin reaction. H341 Suspected of causing genetic defects. H350 May cause cancer. H372 Causes damage to organs through prolonged or repeated exposure. H314 Causes severe skin burns and eye damage. H360F May damage fertility.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/ doctor. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/ doctor. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.